(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 33.34 | 68.02 | -50.99 | 70.20 | 185.12 | -62.08 | 148.66 | 267.16 | -44.36 |
| Other Income | 0.82 | 0.98 | -16.33 | 0.82 | 0.98 | -16.33 | 0.00 | 0.00 | 0.00 |
| PBIDT | 1.25 | 1.49 | -16.11 | 3.57 | 4.04 | -11.63 | 5.15 | 6.09 | -15.44 |
| Interest | 0.18 | 0.21 | -14.29 | 0.49 | 0.61 | -19.67 | 0.98 | 1.50 | -34.67 |
| PBDT | 1.07 | 1.28 | -16.41 | 3.08 | 3.43 | -10.20 | 4.17 | 4.59 | -9.15 |
| Depreciation | 0.60 | 0.60 | 0.00 | 1.70 | 1.40 | 21.43 | 2.25 | 2.73 | -17.58 |
| PBT | 0.47 | 0.68 | -30.88 | 1.38 | 2.03 | -32.02 | 1.92 | 1.86 | 3.23 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 0.47 | 0.68 | -30.88 | 1.38 | 2.03 | -32.02 | 1.92 | 1.86 | 3.23 |
| Equity | 154.99 | 154.99 | 0.00 | 154.99 | 154.99 | 0.00 | 155.49 | 155.49 | 0.00 |
| PBIDTM(%) | 3.75 | 2.19 | 71.16 | 5.09 | 2.18 | 133.02 | 3.46 | 2.28 | 51.98 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: